fda glp-1 warning news november 2025 warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain FDA issues 30 warning letters

Thirst (including polydipsia) was reported in 0%, 1.7%, and 1.5% for placebo, empagliflozin 10 mg, and empagliflozin 25 mg, respectively

(By writing to us, you are agreeing to let The Atlantic use your response, which we may edit for length or clarity

For GLP-1 injections from a vial, fixed needle syringes are strongly preferred

Click Here to report it

The MUSC Health Weight Management Center provides a variety of evidence-based programs designed to support people on their weight loss journey, regardless of whether weight loss medications are part of their treatment plan

The final coverage call After completing thorough clinical, affordability, and oversight evaluations, Capital Blue Cross decided to place oral Wegovy on the same formulary tier as the injectable version, reflecting comparable clinical value and similar expectations around appropriate use